DESKTOP METAL, INC. CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share amounts) |
||||||||
|
|
|
|
|
|
|
||
|
|
December 31, |
||||||
|
|
2022 |
|
2021 |
||||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
76,291 |
|
|
$ |
65,017 |
|
Current portion of restricted cash |
|
|
4,510 |
|
|
|
2,129 |
|
Short‑term investments |
|
|
108,243 |
|
|
|
204,569 |
|
Accounts receivable |
|
|
38,481 |
|
|
|
46,687 |
|
Inventory |
|
|
91,736 |
|
|
|
65,399 |
|
Prepaid expenses and other current assets |
|
|
17,155 |
|
|
|
18,208 |
|
Total current assets |
|
|
336,416 |
|
|
|
402,009 |
|
Restricted cash, net of current portion |
|
|
1,112 |
|
|
|
1,112 |
|
Property and equipment, net |
|
|
56,271 |
|
|
|
58,710 |
|
Goodwill |
|
|
112,955 |
|
|
|
639,301 |
|
Intangible assets, net |
|
|
219,830 |
|
|
|
261,984 |
|
Other noncurrent assets |
|
|
27,763 |
|
|
|
25,480 |
|
Total Assets |
|
$ |
754,347 |
|
|
$ |
1,388,596 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
25,105 |
|
|
$ |
31,558 |
|
Customer deposits |
|
|
11,526 |
|
|
|
14,137 |
|
Current portion of lease liability |
|
|
5,730 |
|
|
|
5,527 |
|
Accrued expenses and other current liabilities |
|
|
26,723 |
|
|
|
33,829 |
|
Current portion of deferred revenue |
|
|
13,719 |
|
|
|
18,189 |
|
Current portion of long‑term debt, net of deferred financing costs |
|
|
584 |
|
|
|
825 |
|
Total current liabilities |
|
|
83,387 |
|
|
|
104,065 |
|
Long-term debt, net of current portion |
|
|
311 |
|
|
|
548 |
|
Convertible notes |
|
|
111,834 |
|
|
|
— |
|
Contingent consideration, net of current portion |
|
|
— |
|
|
|
4,183 |
|
Lease liability, net of current portion |
|
|
17,860 |
|
|
|
13,077 |
|
Deferred revenue, net of current portion |
|
|
3,664 |
|
|
|
4,508 |
|
Deferred tax liability |
|
|
8,430 |
|
|
|
10,695 |
|
Other noncurrent liabilities |
|
|
1,359 |
|
|
|
3,170 |
|
Total liabilities |
|
|
226,845 |
|
|
|
140,246 |
|
Commitments and Contingencies (Note 17) |
|
|
|
|
|
|
||
Stockholders’ Equity |
|
|
|
|
|
|
||
Preferred Stock, $0.0001 par value—authorized, 50,000,000 shares; no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively |
|
|
— |
|
|
|
— |
|
Common Stock, $0.0001 par value—500,000,000 shares authorized; 318,235,106 and 311,737,858 shares issued at December 31, 2022 and December 31, 2021, respectively, 318,133,434 and 311,473,950 shares outstanding at December 31, 2022 and December 31, 2021, respectively |
|
|
32 |
|
|
|
31 |
|
Additional paid‑in capital |
|
|
1,874,792 |
|
|
|
1,823,344 |
|
Accumulated deficit |
|
|
(1,308,954 |
) |
|
|
(568,611 |
) |
Accumulated other comprehensive loss |
|
|
(38,368 |
) |
|
|
(6,414 |
) |
Total Stockholders’ Equity |
|
|
527,502 |
|
|
|
1,248,350 |
|
Total Liabilities and Stockholders’ Equity |
|
$ |
754,347 |
|
|
$ |
1,388,596 |
|
DESKTOP METAL, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
Years Ended December 31, |
||||||||||
|
|
2022 |
|
2021 |
|
2020 |
||||||
Revenues |
|
|
|
|
|
|
|
|
|
|||
Products |
|
$ |
190,248 |
|
|
$ |
105,994 |
|
|
$ |
13,718 |
|
Services |
|
|
18,775 |
|
|
|
6,414 |
|
|
|
2,752 |
|
Total revenues |
|
|
209,023 |
|
|
|
112,408 |
|
|
|
16,470 |
|
Cost of sales |
|
|
|
|
|
|
|
|
|
|||
Products |
|
|
178,952 |
|
|
|
87,450 |
|
|
|
26,945 |
|
Services |
|
|
15,000 |
|
|
|
6,665 |
|
|
|
4,574 |
|
Total cost of sales |
|
|
193,952 |
|
|
|
94,115 |
|
|
|
31,519 |
|
Gross profit (loss) |
|
|
15,071 |
|
|
|
18,293 |
|
|
|
(15,049 |
) |
Operating expenses |
|
|
|
|
|
|
|
|
|
|||
Research and development |
|
|
96,878 |
|
|
|
68,131 |
|
|
|
43,136 |
|
Sales and marketing |
|
|
68,091 |
|
|
|
47,995 |
|
|
|
13,136 |
|
General and administrative |
|
|
83,065 |
|
|
|
78,041 |
|
|
|
20,734 |
|
In-process research and development assets acquired |
|
|
— |
|
|
|
25,581 |
|
|
|
— |
|
Goodwill impairment |
|
|
498,800 |
|
|
|
— |
|
|
|
— |
|
Total operating expenses |
|
|
746,834 |
|
|
|
219,748 |
|
|
|
77,006 |
|
Loss from operations |
|
|
(731,763 |
) |
|
|
(201,455 |
) |
|
|
(92,055 |
) |
Change in fair value of warrant liability |
|
|
— |
|
|
|
(56,576 |
) |
|
|
56,417 |
|
Interest expense |
|
|
(1,743 |
) |
|
|
(149 |
) |
|
|
(328 |
) |
Interest and other (expense) income, net |
|
|
(8,335 |
) |
|
|
(11,822 |
) |
|
|
1,011 |
|
Loss before income taxes |
|
|
(741,841 |
) |
|
|
(270,002 |
) |
|
|
(34,955 |
) |
Income tax benefit |
|
|
1,498 |
|
|
|
29,668 |
|
|
|
940 |
|
Net loss |
|
$ |
(740,343 |
) |
|
$ |
(240,334 |
) |
|
$ |
(34,015 |
) |
Net loss per share—basic and diluted |
|
$ |
(2.35 |
) |
|
$ |
(0.92 |
) |
|
$ |
(0.22 |
) |
Weighted average shares outstanding, basic and diluted |
|
|
314,817 |
|
|
|
260,770 |
|
|
|
157,906 |
|
DESKTOP METAL, INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (in thousands) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
Years Ended December 31, |
||||||||||
|
|
2022 |
|
2021 |
|
2020 |
||||||
Net loss |
|
$ |
(740,343 |
) |
|
$ |
(240,334 |
) |
|
$ |
(34,015 |
) |
Other comprehensive (loss) income, net of taxes: |
|
|
|
|
|
|
|
|
|
|||
Unrealized gain (loss) on available-for-sale marketable securities, net |
|
|
(290 |
) |
|
|
(40 |
) |
|
|
(84 |
) |
Foreign currency translation adjustment |
|
|
(31,664 |
) |
|
|
(6,365 |
) |
|
|
— |
|
Total comprehensive (loss) income, net of taxes of $0 |
|
$ |
(772,297 |
) |
|
$ |
(246,739 |
) |
|
$ |
(34,099 |
) |
DESKTOP METAL, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (in thousands, except share amounts) |
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
Comprehensive |
|
Total |
||||||||||
|
|
Legacy Convertible Preferred Stock |
|
|
Common Stock |
|
Paid‑in |
|
Accumulated |
|
(Loss) |
|
Stockholders’ |
|||||||||||||||||
|
|
Shares |
|
Amount |
|
|
Shares |
|
Amount |
|
Capital |
|
Deficit |
|
Income |
|
Equity |
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
BALANCE—January 1, 2020 |
|
100,038,109 |
|
|
$ |
436,553 |
|
|
|
26,813,113 |
|
|
$ |
3 |
|
$ |
16,722 |
|
|
$ |
(294,262 |
) |
|
$ |
75 |
|
|
$ |
(277,462 |
) |
Retroactive application of recapitalization (Note 1) |
|
(100,038,109 |
) |
|
|
(436,553 |
) |
|
|
128,100,821 |
|
|
|
13 |
|
|
436,520 |
|
|
|
— |
|
|
|
— |
|
|
|
436,533 |
|
Adjusted balance, beginning of period |
|
— |
|
|
|
— |
|
|
|
154,913,934 |
|
|
|
16 |
|
|
453,242 |
|
|
|
(294,262 |
) |
|
|
75 |
|
|
|
159,071 |
|
Exercise of Common Stock options |
|
— |
|
|
|
— |
|
|
|
521,925 |
|
|
|
— |
|
|
325 |
|
|
|
— |
|
|
|
— |
|
|
|
325 |
|
Vesting of restricted Common Stock |
|
— |
|
|
|
— |
|
|
|
5,307,357 |
|
|
|
1 |
|
|
6 |
|
|
|
— |
|
|
|
— |
|
|
|
7 |
|
Issuance of Common Stock in connection with acquisitions |
|
— |
|
|
|
— |
|
|
|
61,060 |
|
|
|
— |
|
|
500 |
|
|
|
— |
|
|
|
— |
|
|
|
500 |
|
Repurchase of shares for employee tax withholdings |
|
— |
|
|
|
— |
|
|
|
(9,308 |
) |
|
|
— |
|
|
(101 |
) |
|
|
— |
|
|
|
— |
|
|
|
(101 |
) |
Stock‑based compensation expense |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
8,006 |
|
|
|
— |
|
|
|
— |
|
|
|
8,006 |
|
Common Stock warrants issued and exercised |
|
— |
|
|
|
— |
|
|
|
692,366 |
|
|
|
— |
|
|
1,915 |
|
|
|
— |
|
|
|
— |
|
|
|
1,915 |
|
Reverse recapitalization, net of transaction costs |
|
— |
|
|
|
— |
|
|
|
63,139,263 |
|
|
|
6 |
|
|
380,295 |
|
|
|
— |
|
|
|
— |
|
|
|
380,301 |
|
Net loss |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
(34,015 |
) |
|
|
— |
|
|
|
(34,015 |
) |
Other comprehensive income |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
(84 |
) |
|
|
(84 |
) |
BALANCE—December 31, 2020 |
|
— |
|
|
$ |
— |
|
|
|
224,626,597 |
|
|
$ |
23 |
|
$ |
844,188 |
|
|
$ |
(328,277 |
) |
|
$ |
(9 |
) |
|
$ |
515,925 |
|
Exercise of Common Stock options |
|
— |
|
|
|
— |
|
|
|
5,732,247 |
|
|
|
1 |
|
|
6,425 |
|
|
|
— |
|
|
|
— |
|
|
|
6,426 |
|
Vesting of restricted Common Stock |
|
— |
|
|
|
— |
|
|
|
491,293 |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Repurchase of shares for employee tax withholdings - RSA |
|
— |
|
|
|
— |
|
|
|
(109,150 |
) |
|
|
— |
|
|
(958 |
) |
|
|
— |
|
|
|
— |
|
|
|
(958 |
) |
Vesting of restricted share units |
|
— |
|
|
|
— |
|
|
|
650,777 |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Repurchase of shares for employee tax withholdings - RSU |
|
— |
|
|
|
— |
|
|
|
(61,498 |
) |
|
|
— |
|
|
(541 |
) |
|
|
— |
|
|
|
— |
|
|
|
(541 |
) |
Issuance of Common Stock in connection with acquisitions |
|
— |
|
|
|
— |
|
|
|
57,267,401 |
|
|
|
5 |
|
|
620,585 |
|
|
|
— |
|
|
|
— |
|
|
|
620,590 |
|
Issuance of Common Stock in connection with acquired in-process research and development |
|
— |
|
|
|
— |
|
|
|
334,370 |
|
|
|
— |
|
|
4,300 |
|
|
|
— |
|
|
|
— |
|
|
|
4,300 |
|
Stock‑based compensation expense |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
28,778 |
|
|
|
— |
|
|
|
— |
|
|
|
28,778 |
|
Vesting of Trine Founder Shares |
|
— |
|
|
|
— |
|
|
|
1,850,938 |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Common Stock issued in connection with warrants exercised |
|
— |
|
|
|
— |
|
|
|
20,690,975 |
|
|
|
2 |
|
|
320,567 |
|
|
|
— |
|
|
|
— |
|
|
|
320,569 |
|
Net loss |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
(240,334 |
) |
|
|
— |
|
|
|
(240,334 |
) |
Other comprehensive loss |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
(6,405 |
) |
|
|
(6,405 |
) |
BALANCE—December 31, 2021 |
|
— |
|
|
$ |
— |
|
|
|
311,473,950 |
|
|
$ |
31 |
|
$ |
1,823,344 |
|
|
$ |
(568,611 |
) |
|
$ |
(6,414 |
) |
|
$ |
1,248,350 |
|
Exercise of Common Stock options |
|
— |
|
|
|
— |
|
|
|
2,310,931 |
|
|
|
— |
|
|
3,190 |
|
|
|
— |
|
|
|
— |
|
|
|
3,190 |
|
Vesting of restricted Common Stock |
|
— |
|
|
|
— |
|
|
|
157,131 |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Vesting of restricted share units |
|
— |
|
|
|
— |
|
|
|
4,153,939 |
|
|
|
1 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
Repurchase of shares for employee tax withholdings - RSU |
|
— |
|
|
|
— |
|
|
|
(74,719 |
) |
|
|
— |
|
|
(243 |
) |
|
|
— |
|
|
|
— |
|
|
|
(243 |
) |
Issuance of common stock related to settlement of contingent consideration |
|
|
|
|
|
|
|
112,202 |
|
|
|
— |
|
|
500 |
|
|
|
— |
|
|
|
— |
|
|
|
500 |
|
||
Stock‑based compensation expense |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
48,001 |
|
|
|
— |
|
|
|
— |
|
|
|
48,001 |
|
Net loss |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
(740,343 |
) |
|
|
— |
|
|
|
(740,343 |
) |
Other comprehensive loss |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
(31,954 |
) |
|
|
(31,954 |
) |
BALANCE—December 31, 2022 |
|
— |
|
|
$ |
— |
|
|
|
318,133,434 |
|
|
$ |
32 |
|
$ |
1,874,792 |
|
|
$ |
(1,308,954 |
) |
|
$ |
(38,368 |
) |
|
$ |
527,502 |
|
DESKTOP METAL, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
Years Ended December 31, |
||||||||||
|
|
2022 |
|
2021 |
|
2020 |
||||||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|||
Net loss |
|
$ |
(740,343 |
) |
|
$ |
(240,334 |
) |
|
$ |
(34,015 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
|
|||
Depreciation and amortization |
|
|
50,767 |
|
|
|
24,854 |
|
|
|
8,589 |
|
Stock‑based compensation |
|
|
48,001 |
|
|
|
28,778 |
|
|
|
8,006 |
|
Goodwill impairment |
|
|
498,800 |
|
|
|
— |
|
|
|
— |
|
Change in fair value of warrant liability |
|
|
— |
|
|
|
56,576 |
|
|
|
(56,417 |
) |
Change in fair value of subscription agreement |
|
|
— |
|
|
|
2,920 |
|
|
|
— |
|
Expense related to Common Stock warrants issued |
|
|
— |
|
|
|
— |
|
|
|
1,915 |
|
Amortization (accretion) of discount on investments |
|
|
(888 |
) |
|
|
3,021 |
|
|
|
75 |
|
Amortization of debt financing cost |
|
|
— |
|
|
|
9 |
|
|
|
19 |
|
Amortization of deferred costs on convertible notes |
|
|
453 |
|
|
|
— |
|
|
|
— |
|
Provision for bad debt |
|
|
975 |
|
|
|
447 |
|
|
|
377 |
|
Provision for slow-moving, obsolete, and lower of cost or net realizable value inventories, net |
|
|
(45 |
) |
|
|
— |
|
|
|
— |
|
Acquired in-process research and development |
|
|
— |
|
|
|
25,581 |
|
|
|
— |
|
Loss on disposal of property and equipment |
|
|
224 |
|
|
|
74 |
|
|
|
18 |
|
Foreign exchange (gains) losses on intercompany transactions, net |
|
|
259 |
|
|
|
182 |
|
|
|
— |
|
Net increase (decrease) in accrued interest related to marketable securities |
|
|
847 |
|
|
|
(819 |
) |
|
|
(3 |
) |
Net unrealized (gain) loss on equity investment |
|
|
6,332 |
|
|
|
9,660 |
|
|
|
— |
|
Net unrealized (gain) loss on other investments |
|
|
1,595 |
|
|
|
(130 |
) |
|
|
— |
|
Deferred tax benefit |
|
|
(1,498 |
) |
|
|
(29,668 |
) |
|
|
(940 |
) |
Change in fair value of contingent consideration |
|
|
(1,567 |
) |
|
|
(429 |
) |
|
|
— |
|
Foreign currency transaction (gain) loss |
|
|
44 |
|
|
|
7 |
|
|
|
— |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
|
|||
Accounts receivable |
|
|
6,737 |
|
|
|
(18,299 |
) |
|
|
(2,370 |
) |
Inventory |
|
|
(28,183 |
) |
|
|
(16,962 |
) |
|
|
(1,303 |
) |
Prepaid expenses and other current assets |
|
|
1,787 |
|
|
|
(8,937 |
) |
|
|
901 |
|
Other assets |
|
|
2,505 |
|
|
|
(3 |
) |
|
|
— |
|
Accounts payable |
|
|
(6,595 |
) |
|
|
12,797 |
|
|
|
(2,637 |
) |
Accrued expenses and other current liabilities |
|
|
(10,613 |
) |
|
|
(8,761 |
) |
|
|
(2,391 |
) |
Customer deposits |
|
|
(2,037 |
) |
|
|
(2,569 |
) |
|
|
(845 |
) |
Current portion of deferred revenue |
|
|
(4,749 |
) |
|
|
5,989 |
|
|
|
774 |
|
Change in right of use assets and lease liabilities, net |
|
|
(4,298 |
) |
|
|
(641 |
) |
|
|
(328 |
) |
Other liabilities |
|
|
(41 |
) |
|
|
1,609 |
|
|
|
— |
|
Net cash used in operating activities |
|
|
(181,531 |
) |
|
|
(155,048 |
) |
|
|
(80,575 |
) |
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|||
Purchases of property and equipment |
|
|
(11,517 |
) |
|
|
(7,683 |
) |
|
|
(1,429 |
) |
Purchase of other investments |
|
|
— |
|
|
|
(3,620 |
) |
|
|
(3,000 |
) |
Proceeds from other investments |
|
|
3,155 |
|
|
|
— |
|
|
|
— |
|
Purchase of equity investment |
|
|
— |
|
|
|
(20,000 |
) |
|
|
— |
|
Proceeds from sale of property and equipment |
|
|
6 |
|
|
|
44 |
|
|
|
— |
|
Proceeds from policy buyout |
|
|
— |
|
|
|
333 |
|
|
|
— |
|
Purchase of marketable securities |
|
|
(158,404 |
) |
|
|
(330,873 |
) |
|
|
(136,286 |
) |
Proceeds from sales and maturities of marketable securities |
|
|
248,150 |
|
|
|
243,349 |
|
|
|
109,016 |
|
Proceeds from capital grant |
|
|
200 |
|
|
|
— |
|
|
|
— |
|
Cash paid to acquire in-process research and development |
|
|
— |
|
|
|
(21,220 |
) |
|
|
— |
|
Cash paid for acquisitions, net of cash acquired |
|
|
(23 |
) |
|
|
(287,624 |
) |
|
|
(5,284 |
) |
Net cash provided by (used in) investing activities |
|
|
81,567 |
|
|
|
(427,294 |
) |
|
|
(36,983 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|||
Proceeds from reverse recapitalization, net of issuance costs |
|
|
— |
|
|
|
— |
|
|
|
534,597 |
|
Proceeds from the exercise of stock options |
|
|
3,190 |
|
|
|
6,426 |
|
|
|
325 |
|
Proceeds from the exercise of stock warrants |
|
|
— |
|
|
|
170,665 |
|
|
|
— |
|
Payment of taxes related to net share settlement upon vesting of restricted stock units |
|
|
(243 |
) |
|
|
(541 |
) |
|
|
— |
|
Repayment of loans |
|
|
(542 |
) |
|
|
— |
|
|
|
— |
|
Proceeds from issuance of convertible notes |
|
|
115,000 |
|
|
|
— |
|
|
|
— |
|
Costs incurred in connection with the issuance of convertible notes |
|
|
(3,619 |
) |
|
|
— |
|
|
|
— |
|
Proceeds from PPP loan |
|
|
— |
|
|
|
— |
|
|
|
5,379 |
|
Repayment of PPP loan |
|
|
— |
|
|
|
— |
|
|
|
(5,379 |
) |
Repayment of term loan |
|
|
— |
|
|
|
(10,000 |
) |
|
|
— |
|
Net cash provided by financing activities |
|
|
113,786 |
|
|
|
166,550 |
|
|
|
534,922 |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
(167 |
) |
|
|
(87 |
) |
|
|
— |
|
Net increase (decrease) in cash, cash equivalents, and restricted cash |
|
|
13,655 |
|
|
|
(415,879 |
) |
|
|
417,364 |
|
Cash, cash equivalents, and restricted cash at beginning of period |
|
|
68,258 |
|
|
|
484,137 |
|
|
|
66,773 |
|
Cash, cash equivalents, and restricted cash at end of period |
|
$ |
81,913 |
|
|
$ |
68,258 |
|
|
$ |
484,137 |
|
|
|
|
|
|
|
|
|
|
|
|||
Supplemental disclosures of cash flow information |
|
|
|
|
|
|
|
|
|
|||
Reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total shown in the condensed consolidated statements of cash flows: |
|
|
|
|
|
|
|
|
|
|||
Cash and cash equivalents |
|
$ |
76,291 |
|
|
$ |
65,017 |
|
|
$ |
483,525 |
|
Restricted cash included in other current assets |
|
|
4,510 |
|
|
|
2,129 |
|
|
|
— |
|
Restricted cash included in other noncurrent assets |
|
|
1,112 |
|
|
|
1,112 |
|
|
|
612 |
|
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows |
|
$ |
81,913 |
|
|
$ |
68,258 |
|
|
$ |
484,137 |
|
|
|
|
|
|
|
|
|
|
|
|||
Supplemental cash flow information: |
|
|
|
|
|
|
|
|
|
|||
Interest paid |
|
$ |
3,488 |
|
|
$ |
148 |
|
|
$ |
322 |
|
Taxes paid |
|
$ |
— |
|
|
$ |
150 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|||
Non‑cash investing and financing activities: |
|
|
|
|
|
|
|
|
|
|||
Net liabilities assumed from Trine Business Combination |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
152,395 |
|
Accrued reverse recapitalization transaction costs |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,901 |
|
Net unrealized (gain) loss on investments |
|
$ |
290 |
|
|
$ |
40 |
|
|
$ |
— |
|
Exercise of private placement warrants |
|
$ |
— |
|
|
$ |
149,904 |
|
|
$ |
— |
|
Common Stock issued for acquisitions |
|
$ |
— |
|
|
$ |
620,590 |
|
|
$ |
500 |
|
Common Stock issued for acquisition of in-process research and development |
|
$ |
— |
|
|
$ |
4,300 |
|
|
$ |
— |
|
Common Stock issued for settlement of contingent consideration |
|
$ |
500 |
|
|
$ |
— |
|
|
$ |
— |
|
Accrued purchase price related to acquisitions |
|
$ |
— |
|
|
$ |
1,800 |
|
|
$ |
200 |
|
Additions to right of use assets and lease liabilities |
|
$ |
10,812 |
|
|
$ |
5,582 |
|
|
$ |
— |
|
Purchase of property and equipment included in accounts payable |
|
$ |
516 |
|
|
$ |
90 |
|
|
$ |
— |
|
Purchase of property and equipment included in accrued expense |
|
$ |
— |
|
|
$ |
38 |
|
|
$ |
— |
|
Transfers from property and equipment to inventory |
|
$ |
4,993 |
|
|
$ |
1,068 |
|
|
$ |
— |
|
Transfers from inventory to property and equipment |
|
$ |
4,513 |
|
|
$ |
1,435 |
|
|
$ |
— |
|
Accrued contingent consideration in connection with acquisitions |
|
$ |
— |
|
|
$ |
6,083 |
|
|
$ |
— |
|
Taxes related to net share settlement upon vesting of restricted stock awards in accrued expense |
|
$ |
— |
|
|
$ |
958 |
|
|
$ |
— |
|
Tax liabilities related to withholdings on Common Stock issued in connection with acquisitions |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
102 |
|
Deferred contract costs |
|
$ |
1,341 |
|
|
$ |
— |
|
|
$ |
— |
|
Equipment financing |
|
$ |
175 |
|
|
$ |
— |
|
|
$ |
— |
|